Literature DB >> 34145437

Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.

Carolina Lucas1, Jon Klein1, Maria E Sundaram2,3, Feimei Liu1, Patrick Wong1, Julio Silva1, Tianyang Mao1, Ji Eun Oh1, Subhasis Mohanty1,4, Jiefang Huang1,4, Maria Tokuyama1, Peiwen Lu1, Arvind Venkataraman1, Annsea Park1, Benjamin Israelow1,4, Chantal B F Vogels5, M Catherine Muenker5, C-Hong Chang6, Arnau Casanovas-Massana5, Adam J Moore5, Joseph Zell7, John B Fournier4, Anne L Wyllie5, Melissa Campbell4, Alfred I Lee8, Hyung J Chun6, Nathan D Grubaugh5, Wade L Schulz9,10, Shelli Farhadian4, Charles Dela Cruz11, Aaron M Ring1, Albert C Shaw1,4, Adam V Wisnewski7, Inci Yildirim12,13, Albert I Ko4,5, Saad B Omer4,5,13, Akiko Iwasaki14,15.   

Abstract

Entities:  

Year:  2021        PMID： 34145437      PMCID： PMC8212078          DOI： 10.1038/s41591-021-01416-4

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   87.241


× No keyword cloud information.
Correction to: Nature Medicine 10.1038/s41591-021-01355-0, published online 5 May 2021. In the version of this article initially published, two author names (Alfred Lee and Saad Omer) were missing the middle initial. The correct names are ‘Alfred I. Lee’ and ‘Saad B. Omer’ (respectively). The errors have been corrected in the HTML and PDF versions of the article.
  3 in total

1.  Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms.

Authors:  Budhaditya Chatterjee; Harshbir Singh Sandhu; Narendra M Dixit
Journal:  PLoS Pathog       Date:  2022-06-27       Impact factor: 7.464

2.  Functionality of Monoclonal Antibody Therapy in SARS-CoV-2.

Authors:  Ruhma Ali; Aditya Patel; Muhammad A Waqas; Krunal Trivedi; Jihad Slim
Journal:  J Med Cases       Date:  2022-08-19

3.  Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).

Authors:  Sabrina Jotschke; Susann Schulze; Nadja Jaekel; Beatrice Ludwig-Kraus; Robby Engelmann; Frank Bernhard Kraus; Christina Zahn; Nicole Nedlitz; Gabriele Prange-Krex; Johannes Mohm; Bettina Peuser; Maik Schwarz; Claudia Spohn; Timo Behlendorf; Mascha Binder; Christian Junghanss; Sebastian Böttcher; Haifa Kathrin Al-Ali
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.